Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02744352 · ClinicalTrials.gov registry record · NA
Single Shot vs Catheter Infraclavicular Brachial Plexus Block After Distal Radius Fracture Repair
A NA study, sponsored by University of Pennsylvania.
- Terminated
- Registry status
- NA
- Development phase
- 8
- Enrollment target
NCT02744352: Clinical Trial NA study, sponsored by University of Pennsylvania.
NCT02744352 is a NA study that was terminated before completion, run by University of Pennsylvania. The registered enrollment target is 8 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02744352, a NA study, was terminated before completion, sponsored by University of Pennsylvania.
- TERMINATED
- Registry status
- NA
- Development phase
- 8 participants
- Enrollment target
Study Summary
The purpose of this study is to compare infraclavicular brachial plexus shot single shot block to continuous catheter nerve block done in adult patients who have under gone surgery to repair distal radius fractures. Visual analogue scores, opioid consumption, quality of recovery and quality of sleep up to 72 hours post operatively will be used for comparison.
Interventions
- DRUG 20ml bolus of 0.5% ropivicaine
- DRUG 0.2% of ropivacaine at 8 milliliter/hour
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 8 participants |
| Start Date | 2016-10 |
| Est. Completion | 2018-10-05 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02744352
The ClinicalTrials.gov registry entry for NCT02744352 describes a study currently listed as terminated, categorized as NA. The registered enrollment target is 8 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Pennsylvania, which has 1,423 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which 20ml bolus of 0.5% ropivicaine is the first listed.
NCT02744352 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02744352 about?
NCT02744352 is a clinical study titled "Single Shot vs Catheter Infraclavicular Brachial Plexus Block After Distal Radius Fracture Repair". The purpose of this study is to compare infraclavicular brachial plexus shot single shot block to continuous catheter nerve block done in adult patients who have under gone surgery to repair distal radius fractures. Visual analogue scores, opioid consumption, quality of recovery and quality of sleep...
What is the current status of trial NCT02744352?
This trial is currently terminated. It is a NA study. The enrollment target is 8 participants. The study started on 2016-10. Estimated completion is 2018-10-05.
What interventions are being tested in trial NCT02744352?
The interventions under investigation include: 20ml bolus of 0.5% ropivicaine (DRUG), 0.2% of ropivacaine at 8 milliliter/hour (DRUG).
Who is sponsoring clinical trial NCT02744352?
This trial is sponsored by University of Pennsylvania, which has 1,423 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.